BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8394027)

  • 1. [Prognostic factors of lung cancer].
    Kleisbauer JP; Thomas P
    Rev Prat; 1993 Apr; 43(7):852-5. PubMed ID: 8394027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma].
    Wolf M
    Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
    Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size.
    Henschke CI; Yankelevitz DF; Miettinen OS;
    Arch Intern Med; 2006 Feb; 166(3):321-5. PubMed ID: 16476872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [To be cured of lung cancer].
    Depierre A; Jacoulet P; Westeel V; Falcoz PE
    Bull Cancer; 2002 Apr; 89(4):351-6. PubMed ID: 12016035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in non-small cell lung cancer.
    Solan MJ; Werner-Wasik M
    Semin Surg Oncol; 2003; 21(2):64-73. PubMed ID: 14508856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lung cancer--epidemiology, prognosis and therapy].
    Martini B
    Med Monatsschr Pharm; 2006 Jun; 29(6):217-21. PubMed ID: 16792198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
    Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
    Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of video-assisted thoracic surgery for stage I/II non-small cell lung cancer.
    Iwasaki A; Shirakusa T; Shiraishi T; Yamamoto S
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):158-64. PubMed ID: 15200996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer treatment present and future.
    Cho JK
    Hawaii Med J; 2003 Mar; 62(3):61-2. PubMed ID: 12703177
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of angiogenesis in operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer.
    Means-Markwell M; Linnoila RI; Williams J; Jänne PA; Kaye F; O'Neil K; Johnson BE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5915-21. PubMed ID: 14676115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in the diagnosis and treatment of lung cancer.
    Gilligan D
    Int J Clin Pract; 1998; 52(5):330-4. PubMed ID: 9796565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IIIB non-small-cell lung cancer.
    Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
    Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.